|
HS Code |
634267 |
| Product Name | Atractylodis Macrocephalae Rhizoma Veterinary Grade API |
| Source | Atractylodes macrocephala rhizome |
| Grade | Veterinary |
| Appearance | Fine powder |
| Usage Forms | Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions |
| Main Active Ingredients | Atractylenolide I, II, III |
| Function | Digestive aid, immune system enhancement |
| Solubility | Partially soluble in water |
| Storage Conditions | Cool, dry place, away from direct sunlight |
| Shelf Life | 2 years |
| Purity | ≥98% (API content) |
| Intended Species | Livestock and companion animals |
| Extraction Method | Water-alcohol extraction |
| Package Options | 1kg, 5kg, 25kg bags |
| Country Of Origin | China |
As an accredited Atractylodis Macrocephalae Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Packaged in 25kg double-layer polyethylene bags within fiber drums, clearly labeled for veterinary use: API for tablets, injections, and more. |
| Shipping | The shipping of Atractylodis Macrocephalae Rhizoma Veterinary Grade API is conducted in secure, moisture-proof, and light-resistant packaging to ensure product stability. All containers are clearly labeled and handled according to international standards for APIs, suitable for tablets, injections, capsules, powders, granules, premix, and solutions, with temperature-controlled options available. |
| Storage | **Storage:** Store Atractylodis Macrocephalae Rhizoma Veterinary Grade API in a tightly sealed, original container at room temperature (15–30°C), protected from moisture, direct sunlight, and excessive heat. Keep in a clean, dry, and well-ventilated area, away from incompatible substances. Ensure the storage area is secure and restricted to authorized personnel. Follow all relevant regulatory and safety guidelines. |
|
Purity 98%: Atractylodis Macrocephalae Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Purity 98% is used in oral premix formulations for livestock, where it ensures consistent anti-inflammatory efficacy and safety. Particle Size D90 < 50μm: Atractylodis Macrocephalae Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Particle Size D90 < 50μm is used in tablet production, where it promotes uniform blending and optimal tablet disintegration. Stability Temperature ≤ 40°C: Atractylodis Macrocephalae Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Stability Temperature ≤ 40°C is used in injectable solutions, where it ensures prolonged shelf life during storage and transportation. Loss on Drying ≤ 5%: Atractylodis Macrocephalae Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Loss on Drying ≤ 5% is used in compounded powder formulations, where it maintains powder flowability and prevents degradation. Heavy Metals ≤ 10 ppm: Atractylodis Macrocephalae Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Heavy Metals ≤ 10 ppm is used in oral capsule manufacturing, where it supports compliance with veterinary safety standards. Microbial Limit ≤ 1000 cfu/g: Atractylodis Macrocephalae Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Microbial Limit ≤ 1000 cfu/g is used in powder feed additives, where it reduces the risk of pathogen contamination. Melting Point 145–150°C: Atractylodis Macrocephalae Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Melting Point 145–150°C is used in granule production, where it provides stability during high-temperature processing. Specific Surface Area ≥ 1 m²/g: Atractylodis Macrocephalae Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Specific Surface Area ≥ 1 m²/g is used in solution preparations, where it enhances dissolution and bioavailability in animal treatments. |
Competitive Atractylodis Macrocephalae Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Over the last decade, we have poured time and resources into developing high-purity Atractylodis Macrocephalae Rhizoma, fit for a broad range of veterinary preparations. In the field, veterinarians and feed producers face rising scrutiny for the transparency, safety, and functional effectiveness of every additive and ingredient in animal health supplements or medicines. As a company directly responsible for the raw material, not a reseller, we have watched these demands shape industry standards and have responded with practical improvements, so our customers do not stumble over gaps in quality or consistency.
It’s not enough for a rhizome extract to meet its target assay; process contaminants, botanical residues, and varying moisture threaten every batch across the sector. By taking direct control—from authenticated raw herb sourcing to proprietary milling and granulation—we’ve prevented batch-to-batch drift in content and flowability, which can otherwise cause compaction problems or weak release in tablets, injectables, or oral solutions. Our process, informed by hands-on failures and iterative testing, has reshaped how we select, dry, and refine the rhizome from the start.
In the veterinary market, applications range from tablets to premixes—and each brings its own technical quirks. Our manufacturing plant produces several standardized grades of Atractylodis Macrocephalae Rhizoma, offering granule, fine powder, and direct compressible pellets. Each lot carries a fixed moisture window and specified granule size, tailored for process lines that demand fast dispersion or low-dust environments.
With feed additives and injectables, undeclared excipients, microbe loads, and chelation issues show up as frequent customer complaints. We keep those stories in mind during QC and release only product that passes microbiological scrutiny, has consistent particle sizing through repeated laser-diffraction analysis, and meets the targeted composition profile. Having the original production records—with traceability back to the actual farmed field—has given us rapid troubleshooting power when a client needs batch data for regulatory reviews.
Some buyers want a granule for dry-mix premix blending, others need a solution-ready API for dissolving, and a growing number expect high-flow powder for tablet compaction. A single process can’t handle all these needs. By running parallel granulation and drying lines, we adjust process time, air speed, and blending endpoints. Our experience has shown that the ideal powder for capsules simply cannot withstand direct tablet pressing without capping or lamination, so we never try to force one model into an unsuitable application—an easy pitfall among general traders or repackers.
For injectables and veterinary solutions, clarity and complete solubility carry real clinical weight. We select rhizome batches with lower fibrous content and blend to increase the ratio of water-soluble polysaccharides, taking care to exclude lots that leave suspended flecks or cause filter clogging. If a client sends feedback on particle settling or color instability, we track back using our production logs and tweak our extraction protocol. This workflow only works when a company owns and controls every step, from field to finished API—a perspective that outside sales channels do not always understand.
Every year brings new requests from veterinary formulators: sometimes a denser pellet with low static charge for robotic dispensers, sometimes an ultrafine powder for even dispersion into bulk feed, sometimes a concentrated API base for large-scale injection. While the market headlines may talk about “natural botanical solutions,” the work required to keep up with such demands often arrives as a six-month trial-and-error journey until someone is able to dial in granule size, water activity, and flow properties.
We discovered early the hard way that even small moisture excess in a rhizome powder will balloon into batch-wide clumping and microbial growth. In capsule and tablet production, high powder moisture has killed more jobs than sieving or bland taste ever did, since it directly triggers sticking and capping during compaction. Rather than tune the spray-drying at the end, we managed to control water content during rhizome pre-processing, using a low-humidity, two-stage dehydration system that keeps total loss-on-drying under 5%. As a result, veterinarians report better shelf life and stability, particularly for blended premixes that may sit in warehouses for months prior to use.
Atractylodis Macrocephalae Rhizoma gained its veterinary reputation as a digestive and tonic ingredient, used across Asia and now growing in international animal health circles. Studies point to polysaccharides and sesquiterpenes as key components for gut health and immune modulation. Our own HPLC analytics, calibrated against published controls, have found that root origin and harvest time shift the active content by more than 20% across the supply chain. Contracting directly with herbal growers, we have proven that scheduled harvest and centralized drying are essential for delivering product above the industry minimum for these actives.
Anticipating further regulatory tightening in both feed and veterinary APIs, our labs screen each batch for pesticide residues, heavy metals, and aflatoxins. This isn’t about dodging compliance—practical experience with rejected export shipments and unstable shelf tests has shown that substandard controls cost more than any lab test. As a result, every specification sheet required by end users comes directly from our own in-house QC, not third-party or undisclosed sub-suppliers.
It’s common in the market to see attractively-priced powders sourced from mixed botanical origins, usually unnamed cultivar blends, processed through multi-tier resellers. Every time we’ve run comparative tests, these generic APIs vary widely in bulk density and dissolve with high turbidity—a clear marker of extraneous plant fibers or unfiltered residue. Such variability triggers formulation headaches in tablet pressing, as well as complaints about inconsistent dosing or flavor in feed premixes. Our technical literature tracks long-term side-by-side stability, confirming that single-origin, sorted rhizome extract resists caking and shifts in color under controlled storage—details that support a veterinarian’s long-term dosing protocols.
Working from genuine plant identification, not anonymous powder lots, has enabled us to isolate the link between rhizome geometry, post-drying handling, and the final product’s ability to flow, compress, or disperse evenly. We have seen batches from mixed sources gum up automated filling lines, shut down tabletop blenders, and trigger hundreds of kilograms in recalls for clients. Direct sourcing and detailed lot histories protect every downstream process, saving both reputation and money.
The journey from raw rhizome to finished API leaves no room for shortcuts. Shipping humidity, bulk packaging, and static charge all change a powder’s characteristics at each stage. After experiencing multiple blocked auger systems and failed feed augments, we realized bulk density measure alone is not enough—powder flow and packaging breathability play just as crucial a role. Our current packaging now uses multilayer barrier bags inside rigid drums, reducing the risk of clumping and oxidation before arrival at customer facilities.
Vets, feed mills, and contract manufacturers asked for practical improvements: packaging that resists punctures and responds well to automated turntables, as well as labels with actual lot history, not just random IDs. We have answered by printing unique barcodes and producing batch reports tied to every export container. This has led to faster regulatory clearances and smoother logistics throughout our supply chains, giving veterinarians and procurement teams direct access to the traceability tools they need when regulatory inspectors arrive.
One of the fastest-growing challenges in the veterinary space is the shift toward block-chain audits, QR-based lot verification, and fully digital recordkeeping in drug and supplement APIs. We keep up by investing in electronic batch production records, which allow real-time replies to audit demands from both veterinary authorities and feed production partners. Documentation, once a tedious paperwork mountain, now links directly from our finished-goods warehouse to the end user’s compliance managers in minutes.
We are seeing increasing crossover from the human pharmaceutical sector in the form of more complex monographs and testing standards for veterinary botanicals. Industry groups and regulators demand transparent source-of-origin data and ban on undeclared adjuncts or blending. Rather than novel, these demands echo our own motivations—to avoid costly failures and build honest, long-term business with repeat customers who rely on consistent, safe ingredients. By taking the extra time to generate electronic certificates and upload real-time COA data, we help clients stay ahead in the documentation race.
Veterinary medicine rarely stands still. Increasingly, our partners are examining Atractylodis Macrocephalae Rhizoma as a base for modern delivery forms: slow-release capsules, injectable suspensions, and custom feed supplements. Success depends on how the starting API adapts to new stabilizers, binders, and excipients—technical details that often only come out in mass production, not pilot-scale lab trials.
One feed company’s trial with our ultra-fine API for granule application, for example, revealed sticking problems in their packaging line due to static buildup in winter. We solved this by changing the final sieving mesh and revisiting the anti-caking agent used, based on our direct familiarity with the granule’s fundamental physics. Only a manufacturer working closely with real, full-scale production will catch and answer these issues proactively. Granule hardness, water-uptake during blending, and re-suspension after transport remain on our regular improvement grid, informed by every season’s growing and harvest batch.
Real-world performance guides every product decision we make. Instead of aiming for arbitrary standards, we work directly from veterinary feedback and field complaints to refine target specifications. Time in the laboratory has taught us the hard value of close moisture, particle, and active-ingredient tracking—not simply meeting published benchmarks, but giving veterinarians and feed producers more reliable, easier-to-use building blocks for their final products.
Our technical team operates with a deep respect for the customer’s production line, recognizing that a failed blend or clogged filter costs more than any test batch or certificate. We regularly host quality audits, invite client staff for facility tours, and share batch data for collaborative improvement. Every year, dozens of technical adjustments are made based on customer and in-house QC data, proving that open lines of feedback do more to lift product quality than any single annual review or compliance stamp.
Across hundreds of process runs, certain challenges surface repeatedly. End-users often report powder caking during humid transport or inconsistent blend dispersion. We address this by calibrating bulk powder with anti-caking micro-additives and adjusting the drying profile for better heat penetration and quicker release during granulation. For formulators struggling with solubility in liquid solutions, our team recommends mesh adjustments and solubilizing agents that match the botanical profile, eliminating the haze that plagues generic bulk supplies.
It’s easy to overlook basic packaging flaws—yet each failed shipment or rejected container teaches another lesson in humidity control, double-sealed bags, and drum selection for international transport. By including desiccant systems and regular water activity monitoring, we save our customers from batch failures that stem from excess moisture during ocean or overland shipping.
Manufacturing veterinary APIs goes far beyond scale-up or margin chasing. It’s a long-term commitment to science, field experience, and learning from every batch, every complaint, every changed protocol. Atractylodis Macrocephalae Rhizoma, in our hands, has evolved from a simple root to a customizable platform underpinning a huge range of animal health products. By staying grounded in our own manufacturing shop floor, harvesting data, and listening closely to customers, we have built an ingredient that keeps pace with changing science and field practice—not just today but for the future of veterinary medicine.